Key facts
- Longitude Capital is a venture capital firm based in Menlo Park, CA with 20 tracked portfolio companies.
- Notable positions include IntelyCare, Cohere Health, VeraDermics (NYS: MANE), Nalu Medical, Rivus Pharmaceuticals.
- Private Market View records 3 deal participations by Longitude Capital.
- Longitude Capital’s most recent recorded investment was in May 2025 and 1 over two years.
- The team roster lists 2 people.
Registered with the SEC
Form ADV · 2026-04 · CRD 161916- Regulatory AUM
- —
- Private fund assets
- $2.4B
- Private funds
- 6 · 6 venture
- Staff
- 27
- Registered office
- MENLO PARK, CA
- SEC status
- Approved
Reports custody of client assets.
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as LONGITUDE CAPITAL MANAGEMENT CO., LLC).
Free account
See the whole book
- ·The book's top 25 — of 20 recorded positions
- ·Every recorded deal — 3 rounds
- ·Watchlist + alerts for Longitude Capital's activity
Create free account
No card required
Portfolio, priced
20 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| IntelyCare | — | $1.1B | — | |
| Cohere Health | — | $750.0M | — | |
| VeraDermics (NYS: MANE) | Drug Discovery | $596.3M | — | |
| Nalu Medical | — | $533.0M | — | |
| Rivus Pharmaceuticals | Drug Discovery | $489.0M | — | |
| Aviceda Therapeutics | — | $346.5M | — | |
| OrsoBio | — | $310.0M | — | |
| NOCD | — | $268.7M | — | |
| MicroTransponder | — | $225.0M | — | |
| Endogenex | — | $218.0M | — | |
| CuraSen | — | $119.4M | — | |
| Helicore Biopharma | — | $98.0M | — | |
| Sydnexis | Drug Discovery | $90.0M | — | |
| Norm | — | $84.0M | — | |
| Ventaris Surgical | — | $79.0M | — | |
| + 5 more companies · a free account shows the top of the book | ||||
Recent deals
3 recordedTeam
2 people on record — 2 with verified contacts
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked
- What companies does Longitude Capital invest in?
- Longitude Capital has 20 recorded portfolio companies, including IntelyCare, Cohere Health, VeraDermics (NYS: MANE), Nalu Medical.
- Is Longitude Capital actively investing?
- Longitude Capital's most recent recorded investment was in May 2025.